UNSPSC 51112037: Midostaurin

Midostaurin is a multi-targeted protein kinase inhibitor that has been investigated for the treatment of acute myeloid leukemia (AML), myelodysplastic syndrome (MDS) and advanced systemic mastocytosis. It is a semi-synthetic derivative of staurosporine, an alkaloid from the bacterium Streptomyces staurosporeus.

UNSPSC 51112037 Midostaurin, a Commodity code, shows minimal recent state and local procurement activity directly aligned with the pharmaceutical product itself. The code's nominal scope covers a specific pharmaceutical agent used in oncology treatment, but the recent opportunities dataset contains no solicitations requesting midostaurin or direct pharmaceutical acquisitions under this code's designation. Instead, the posted opportunities reflect broader pharmaceutical and medical supply procurement—including naloxone and drug deactivation systems (Seminole County, Florida), emergency medical services pharmaceuticals and supplies (Tucson Fire Department), forensic drug reference standards (Pinellas County, Florida), and multi-source generic pharmaceuticals through cooperative purchasing (MMCAP). These represent state health departments, county health systems, municipal fire departments, and multi-jurisdictional cooperative alliances, not a concentrated buyer base focused on the specific oncology pharmaceutical this code nominally covers.

Geographic activity spans Florida (Seminole County, Pinellas County), Arizona (Tucson), Minnesota (MMCAP, covering multiple states including Oregon), and Texas (Williamson County coordination). None of these recent opportunities directly solicit midostaurin or demonstrate active state and local demand for this specific drug. The most closely related recent procurement is MMCAP's Request for Proposal for generic multi-source pharmaceuticals and over-the-counter products with proposals due March 26, 2026, but that opportunity encompasses broad pharmaceutical categories rather than oncology-specific agents. Without evidence of recent state or local solicitations specifically requesting midostaurin supply, the code shows limited current pursuit opportunity in the state and local procurement market as presently tagged.